NaviFUSROCO:6872 -1.20%30 Days Payable is 0.00 as of Dec. 2025. GuruFocus rates ROCO:6872 with a GF Score™ of 30/100 and a GF Value™ of NT$10.41 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 794 Medical Devices & Instruments companies, NaviFUS ranks worse than 99.62% on this metric.
NaviFUS's average Accounts Payable for the
three
months ended in Dec. 2025 was NT$0.00 Mil. NaviFUS's Cost of Goods Sold for the
three
months ended in Dec. 2025 was NT$3.05 Mil.
Hence, NaviFUS's Days Payable for the
three
months ended in Dec. 2025 was 0.00.
The historical rank and industry rank for NaviFUS's Days Payable or its related term are showing as below:
ROCO:6872'
s Days Payable Range Over the Past 10 Years
Min: 2.54 Med: 7.75 Max: 8.91
Current: 5.86
During the past 8 years, NaviFUS's highest Days Payable was 8.91. The lowest was 2.54. And the median was 7.75.
ROCO:6872's Days Payable is ranked worse than 99.62% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs ROCO:6872: 5.86
NaviFUS's Days Payable
declined
from Dec. 2024 (4.59) to Dec. 2025 (0.00).
It may suggest that NaviFUSaccelerated paying its suppliers.
NaviFUS Days Payable Related Terms
NaviFUS Days Payable Historical Data
* Premium members only.
The historical data trend for NaviFUS's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6872 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, NaviFUS's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NaviFUS Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, NaviFUS's Days Payable distribution charts can be found below:
* The bar in red indicates where NaviFUS's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
NaviFUS's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NaviFUS (ROCO:6872) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on NaviFUS and its competitors. Over the past decade, NaviFUS's Days Payable has ranged from 2.54 to 8.91. According to the industry distribution chart, NaviFUS ranks #791 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 99.6%.
Is NaviFUS's Days Payable too high?
NaviFUS's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 2.54 to a high of 8.91. Based on the distribution chart, NaviFUS ranks #791 out of 794 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, NaviFUS has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NaviFUS's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, NaviFUS ranks #791 out of 794 companies for Days Payable. This places NaviFUS in the lower half of its industry. The industry median Days Payable is 67.97. Historically, NaviFUS's own Days Payable has ranged from 2.54 to 8.91 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on NaviFUS and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NaviFUS's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NaviFUS stock overvalued right now?
Based on GuruFocus' analysis, NaviFUS (ROCO:6872) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$10.41, compared to a current price of NT$16.50 — trading 58.5% above its estimated fair value. The current Days Payable is 0.00. NaviFUS's overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For NaviFUS (ROCO:6872), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NaviFUS (ROCO:6872) Overvalued in 2026?
Based on GuruFocus' analysis, NaviFUS stock appears to be overvalued.
The current stock price of NT$16.50 is trading 58.5% above its estimated GF Value™ of NT$10.41.
GuruFocus considers NaviFUS to be Significantly Overvalued.
Key valuation signals for ROCO:6872:
Days Payable: 0.00
GF Value™: NT$10.41 vs. price of NT$16.50 (58.5% above fair value)
No single metric tells the full story. See the ROCO:6872 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NaviFUS Corp engaged in developing, manufacturing and selling neuronavigation-guided focused ultrasound systems. The company's activities include Medical device development. The Group operates business only in a single industry. The company generates majority of revenue from Taiwan.
30GF Score
Get the complete analysis for ROCO:6872
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6872 has been successfully added to your 
